Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression.

Oncotarget · 2016 · PMC5356583 · PMID 27626693

Europe PMC DOI

hedged sentences

0.0260

closest p · 0.5× alpha

0.0610

boldest claim

The sentences

marginally significantp=0.026actually significant

However, 3 of them remain significant or marginally significant, i.e., OSMR (p=0.026), TP63 (p=0.028) and CACHD1 (p=0.081), suggesting they carry additional prognostic power.

also in 26,082 other papers

borderline significancep-value=0.061so close (0.05 < p ≤ 0.1)

NLGN4Y expression is also lower in high grade tumors (Gleason score >8) compared to lower grade disease (Gleason score <=8) with borderline significance (Figure 6A , p-value=0.061).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.